Story thread · 4 reports / 4 sources
Amplia teams up with big pharma for lung cancer trial
brisbanetimes.com.au · 7d
How the coverage leans
Across 4 sources · syndicated copies counted once
Amplia Therapeutics and pharmaceutical giant Eli Lilly are teaming up to trial a combination their respective drug therapies for non-small cell lung cancer.
First report: Russia develops prototype vaccine for non-small cell lung cancer — scientist — tass.com, 8d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.